Advertisement

Reactions Weekly

, Volume 1769, Issue 1, pp 260–260 | Cite as

Ipilimumab/nivolumab

Bullous pemphigoid: case report
Case report
  • 13 Downloads

Reference

  1. Hamann C, et al. Immune-related adverse events: A new great mimicker? A case of prurigo nodularis-like bullous pemphigoid due to anti-CTLA-1 and anti-PD-1 inhibitors responding to rituximab. Journal of the American Academy of Dermatology 81 (Suppl. 1): AB222 abstr. 9737, No. 4, Oct 2019. Available from: URL: http://doi.org/10.1016/j.jaad.2019.06.816 [abstract] - Lebanon

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations